372
Participants
Start Date
October 31, 2012
Primary Completion Date
April 30, 2015
Study Completion Date
December 31, 2015
1% tenofovir gel
"Participants will be randomized to receive 1% tenofovir gel through either:~* Public sector family planning services with 2-3 monthly provision and monitoring of 1% tenofovir gel and the use of QI methodology to promote reliable service delivery (intervention arm), or~* The CAPRISA research clinics with monthly provision and monitoring of 1% tenofovir gel (control arm)."
CAPRISA eThekwini Clinical Research Site, Durban
CAPRISA Vulindlela Clinical Research Site, Pietermaritzburg
Collaborators (1)
CONRAD
OTHER
Gilead Sciences
INDUSTRY
FHI 360
OTHER
Institute for Healthcare Improvement
OTHER
Centre for the AIDS Programme of Research in South Africa
NETWORK